Target intelligence / Profile preview

Tryptophan synthase

Molecular classification
Enzyme, Lyase (specifically, carbon-oxygen lyase), Pyridoxal 5′-phosphate (PLP)-dependent enzyme
01

Overview

Tryptophan synthase is a PLP-dependent enzyme complex (EC 4.2.1.20) that catalyzes the final two steps in the biosynthesis of the amino acid tryptophan. It is found in bacteria, fungi, plants, and some protists but is absent from animals. The enzyme typically forms an α2β2 heterotetramer, with TrpA (α subunit) converting indole-3-glycerol phosphate to glyceraldehyde 3-phosphate and indole, and TrpB (β subunit) condensing indole with serine to produce tryptophan[1][3][5]. The catalytic mechanism involves a hydrophobic channel that efficiently transfers indole between subunits, illustrating the concept of substrate channeling. Tryptophan synthase is classically used as a model for allostery, vectorial catalysis, and enzyme structure-function relationships[3][5]. This enzyme is a key target for antibacterial strategies, as its inhibition can prevent growth of organisms that rely on de novo tryptophan biosynthesis but does not affect animals, which lack this pathway. Multiple lines of research have further detailed its evolutionary, mechanistic, and regulatory complexity, with natural and engineered mutants providing deep insight into enzyme function[2][3].

Other names
tryptophan synthetaseTrpABTrpA (α subunit)TrpB (β subunit)
02

Mechanism of action

Competitive inhibition (by molecules that mimic natural substrates or intermediates); Allosteric modulation (inhibition or activation through binding to allosteric sites); Enzyme inhibition/blockade, leading to disruption of tryptophan biosynthesis

03

Biological functions

Amino acid biosynthesis (tryptophan biosynthesis)Substrate channelingAllosteric regulation within multi-subunit enzyme complexes
04

Disease associations

Infection (potential antibacterial target due to absence in animals)Other (possible role in plant defense and secondary metabolism through indole intermediates)
05

Safety considerations

Not present in animals, so enzyme inhibitors may have high selectivity for microbial or plant systems, potentially reducing off-target effects in mammals[1][3][5]. However, disruption could impact microbiomes or plant–microbe interactions.
06

Interacting drugs

No approved clinical drugs, but enzyme inhibitors (often used in microbial studies and antibacterial research)

1 more in the full profile.

07

Biomarkers

Accumulation or depletion of tryptophan or indole-3-glycerol phosphate (in bacterial and plant studies)Levels of indole or other intermediates in relevant organisms

Beyond the preview

Go deeper on Tryptophan synthase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tryptophan synthase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call